OLMESARTAN/ AMLODIPINE HCT INTAS 20/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 20/5/12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmesartan/ amlodipine hct intas 20/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 20/5/12.5 mg film-coated tablet blister pack

accord healthcare pty ltd - olmesartan medoxomil, quantity: 20 mg; hydrochlorothiazide, quantity: 12.5 mg; amlodipine besilate, quantity: 6.95 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; magnesium stearate; lactose monohydrate; silicified microcrystalline cellulose; povidone; isopropyl alcohol; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - olmesartan/ amlodipine hct intas indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

AKM-OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil and hydrochlorothiazide  20/12.5 mg tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

akm-olmesartan hctz 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet bottle pack

pharmacor pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet - excipient ingredients: hyprolose; microcrystalline cellulose; lactose monohydrate; stearic acid; purified water; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

APX-OLMESARTAN/HCTZ 40/12.5 olmesartan medoxomil and hydrochlorothiazide 40/12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apx-olmesartan/hctz 40/12.5 olmesartan medoxomil and hydrochlorothiazide 40/12.5 mg tablet blister pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: hyprolose; lactose monohydrate; magnesium stearate; microcrystalline cellulose; purified water; stearic acid; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

AKM-OLMESARTAN HCTZ 40/12.5 olmesartan medoxomil and hydrochlorothiazide 40/12.5 mg tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

akm-olmesartan hctz 40/12.5 olmesartan medoxomil and hydrochlorothiazide 40/12.5 mg tablet bottle pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 40 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; purified water; stearic acid; lactose monohydrate; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

OLMERTAN COMBI 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

olmertan combi 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet blister pack

pharmacor pty ltd - olmesartan medoxomil, quantity: 20 mg; hydrochlorothiazide, quantity: 12.5 mg - tablet - excipient ingredients: lactose monohydrate; hyprolose; purified water; magnesium stearate; microcrystalline cellulose; stearic acid; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

APX-OLMESARTAN/HCTZ 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apx-olmesartan/hctz 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet blister pack

pharmacor pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet - excipient ingredients: lactose monohydrate; hyprolose; purified water; magnesium stearate; stearic acid; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

APO-OLMESARTAN/AMLODIPINE/HCTZ 20/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 20/5/12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-olmesartan/amlodipine/hctz 20/5/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 20/5/12.5 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - hydrochlorothiazide, quantity: 12.5 mg; amlodipine besilate, quantity: 6.95 mg; olmesartan medoxomil, quantity: 20 mg - tablet, film coated - excipient ingredients: pregelatinised maize starch; silicified microcrystalline cellulose; isopropyl alcohol; magnesium stearate; lactose monohydrate; povidone; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350; iron oxide black - apo-olmesartan/amlodipine/hctz 20/5/12.5 mg is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

APO-OLMESARTAN/AMLODIPINE/HCTZ 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-olmesartan/amlodipine/hctz 40/10/12.5 olmesartan medoxomil/amlodipine/hydrochlorothiazide 40/10/12.5 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 13.9 mg; hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 40 mg - tablet, film coated - excipient ingredients: lactose monohydrate; magnesium stearate; povidone; pregelatinised maize starch; silicified microcrystalline cellulose; isopropyl alcohol; titanium dioxide; purified talc; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - apo-olmesartan/amlodipine/hctz 40/10/12.5 mg is indicated for the treatment of hypertension, either as replacement for olmesartan medoxomil, amlodipine and hydrochlorothiazide being already taken as separate tablets or as add-on therapy where a patient's blood pressure is not controlled on a dual combination. this fixed dose combination is not indicated for initial therapy.

PHARMACOR OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet bottle pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan hctz 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet bottle pack

pharmacor pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet - excipient ingredients: hyprolose; magnesium stearate; stearic acid; lactose monohydrate; purified water; microcrystalline cellulose; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.

PHARMACOR OLMESARTAN HCTZ 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor olmesartan hctz 20/12.5 olmesartan medoxomil and hydrochlorothiazide 20/12.5 mg tablet blister pack

pharmacor pty ltd - hydrochlorothiazide, quantity: 12.5 mg; olmesartan medoxomil, quantity: 20 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; stearic acid; purified water; hyprolose; magnesium stearate; titanium dioxide; hypromellose; purified talc; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - olmesartan medoxomil and hydrochlorothiazide is indicated for:,treatment of hypertension.,treatment should not be initiated with this fixed dose combination.